World Drug Delivery and Formulation Summit 2014

It is estimated that by 2014 the global pharmaceutical industry will be worth over $910 billion. Europe will contribute around a third of this figure, ranking second to the North American market. Due to increased competition from the emerging markets, Europe has suffered in terms of growth post 2009 but still contributes 50%.

As the industry model moves further from that of the blockbusters, companies are under more pressure than ever to push new compounds through development in an effort to see a return on their investments. Europe has a long standing and loyal consumer market, is home to an elite group of highly profitable pharmaceutical companies and has the technical expertise to drive its growth in this area.